Agri Business

Why should we not revoke Bollgard II patent, Centre asks Mahyco Monsanto

KV Kurmanath Hyderabad | Updated on January 20, 2018 Published on March 10, 2016

A file photo of farmer showing Bt cotton bolls destroyed by pinkbollworm, in a field at Kadagamdoddi village near Raichur, Karnataka

Govt acts on a letter from farmers’ union on bollworm developing resistance to technology

Even as it announced a nation-wide uniform price for cottonseed for the upcoming kharif season, the Union government has asked Mahyco Monsanto Biotech (India) Limited why it should not revoke the patent it granted for the Bollgard II technology.



The Department of Industry Policy and Promotion (DIPP) has served a show cause notice to the firm, which sub-licences the transgenic technology to the cottonseed companies in the country.



Show cause notice



The firm, a joint venture between Mahyco and Monsanto, received the licence from Monsanto to sell the technology under bilateral agreements to the seed firms.



The show-cause notice comes in the wake of criticism from the farmers’ unions, non-governmental organisations and seed companies that the pink bollworm had developed resistance to the technology and that the technology was ineffective in addressing the challenge.



They contend that if it is not effective to address the problem there is no need to pay royalty.



The department was acting on a letter from the Union Ministry of Agriculture dated March 3.



“The Minister has received a letter from Bharatiya Janata Party Kisan Morcha. They requested the Minister to stop collection of royalty on Bollgard II technology patent and revoke the patent as it lost efficacy to control pink bollworm,” the letter said.



Citing reports of Central Institute of Cotton Research (CICR) and Directorate of Plant Protection Quarantine and Storage, the letter said that the resistance of the pest to BGII appeared to be fast accelerating.



“We have heard reports that the pest developed resistance in Saurashtra and adjoining areas of Gujarat, Maharashtra, Andhra Pradesh and Madhya Pradesh,” it said.



MMB response



Mahyco Monsanto Biotech (India) Limited has acknowledged the receipt of the notice from DIPP, which works under the Union Ministry of Commerce and Industry. It, however, is yet to respond to the notice.



“We will respond to the same within the stipulated deadline,” an MMB spokesperson told BusinessLine in an e-mailed response.



“This show-cause notice comes against the backdrop of a bilateral commercial dispute where few licensees refused to honour their commitments to pay MMB over ₹450 crore after collecting these amounts from the cotton farmers in Kharif 2015,” he pointed out.



“MMB remains hopeful that with its intent to promote Make in India and commitment to improve ease of doing business, the government will encourage and continue to protect innovation, uphold fair business practices and provide predictability, which can benefit Indian farmers through access to relevant solutions,” he said.



Published on March 10, 2016

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.